BOIRON SA (BOI.PA) Fundamental Analysis & Valuation

EPA:BOI • FR0000061129

Current stock price

27.8 EUR
-0.2 (-0.71%)
Last:

This BOI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BOI.PA Profitability Analysis

1.1 Basic Checks

  • In the past year BOI was profitable.
  • In the past year BOI had a positive cash flow from operations.
  • Each year in the past 5 years BOI has been profitable.
  • In the past 5 years BOI always reported a positive cash flow from operatings.
BOI.PA Yearly Net Income VS EBIT VS OCF VS FCFBOI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

  • BOI has a worse Return On Assets (3.45%) than 60.78% of its industry peers.
  • The Return On Equity of BOI (5.25%) is comparable to the rest of the industry.
  • BOI has a Return On Invested Capital (4.43%) which is comparable to the rest of the industry.
  • BOI had an Average Return On Invested Capital over the past 3 years of 5.61%. This is significantly below the industry average of 17.40%.
Industry RankSector Rank
ROA 3.45%
ROE 5.25%
ROIC 4.43%
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
BOI.PA Yearly ROA, ROE, ROICBOI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • BOI's Profit Margin of 3.84% is in line compared to the rest of the industry. BOI outperforms 41.18% of its industry peers.
  • BOI's Profit Margin has declined in the last couple of years.
  • BOI has a worse Operating Margin (5.26%) than 60.78% of its industry peers.
  • In the last couple of years the Operating Margin of BOI has declined.
  • Looking at the Gross Margin, with a value of 73.71%, BOI is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BOI has remained more or less at the same level.
Industry RankSector Rank
OM 5.26%
PM (TTM) 3.84%
GM 73.71%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
BOI.PA Yearly Profit, Operating, Gross MarginsBOI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BOI.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BOI is destroying value.
  • The number of shares outstanding for BOI remains at a similar level compared to 1 year ago.
  • BOI has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BOI is higher compared to a year ago.
BOI.PA Yearly Shares OutstandingBOI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BOI.PA Yearly Total Debt VS Total AssetsBOI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • BOI has an Altman-Z score of 3.64. This indicates that BOI is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of BOI (3.64) is comparable to the rest of the industry.
  • BOI has a debt to FCF ratio of 0.49. This is a very positive value and a sign of high solvency as it would only need 0.49 years to pay back of all of its debts.
  • BOI has a Debt to FCF ratio of 0.49. This is amongst the best in the industry. BOI outperforms 94.12% of its industry peers.
  • BOI has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • BOI has a better Debt to Equity ratio (0.04) than 86.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.49
Altman-Z 3.64
ROIC/WACC0.56
WACC7.97%
BOI.PA Yearly LT Debt VS Equity VS FCFBOI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

  • BOI has a Current Ratio of 2.39. This indicates that BOI is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of BOI (2.39) is better than 78.43% of its industry peers.
  • A Quick Ratio of 1.46 indicates that BOI should not have too much problems paying its short term obligations.
  • BOI has a better Quick ratio (1.46) than 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.46
BOI.PA Yearly Current Assets VS Current LiabilitesBOI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. BOI.PA Growth Analysis

3.1 Past

  • The earnings per share for BOI have decreased strongly by -18.09% in the last year.
  • BOI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.40% yearly.
  • The Revenue has been growing slightly by 4.80% in the past year.
  • Measured over the past years, BOI shows a decrease in Revenue. The Revenue has been decreasing by -2.63% on average per year.
EPS 1Y (TTM)-18.09%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%

3.2 Future

  • BOI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.73% yearly.
  • Based on estimates for the next years, BOI will show a small growth in Revenue. The Revenue will grow by 5.54% on average per year.
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BOI.PA Yearly Revenue VS EstimatesBOI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
BOI.PA Yearly EPS VS EstimatesBOI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

4

4. BOI.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 24.82, the valuation of BOI can be described as rather expensive.
  • The rest of the industry has a similar Price/Earnings ratio as BOI.
  • The average S&P500 Price/Earnings ratio is at 26.21. BOI is around the same levels.
  • With a Price/Forward Earnings ratio of 12.02, BOI is valued correctly.
  • BOI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BOI is cheaper than 78.43% of the companies in the same industry.
  • BOI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.10.
Industry RankSector Rank
PE 24.82
Fwd PE 12.02
BOI.PA Price Earnings VS Forward Price EarningsBOI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BOI is valued cheaper than 96.08% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, BOI is valued cheaply inside the industry as 82.35% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.08
EV/EBITDA 6.03
BOI.PA Per share dataBOI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.49
PEG (5Y)N/A
EPS Next 2Y2.73%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. BOI.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.62%, BOI is a good candidate for dividend investing.
  • BOI's Dividend Yield is rather good when compared to the industry average which is at 1.94. BOI pays more dividend than 84.31% of the companies in the same industry.
  • BOI's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 4.62%

5.2 History

  • The dividend of BOI decreases each year by -1.41%.
Dividend Growth(5Y)-1.41%
Div Incr Years0
Div Non Decr Years0
BOI.PA Yearly Dividends per shareBOI.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5.3 Sustainability

  • BOI pays out 107.57% of its income as dividend. This is not a sustainable payout ratio.
DP107.57%
EPS Next 2Y2.73%
EPS Next 3YN/A
BOI.PA Yearly Income VS Free CF VS DividendBOI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BOI.PA Dividend Payout.BOI.PA Dividend Payout, showing the Payout Ratio.BOI.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BOI.PA Fundamentals: All Metrics, Ratios and Statistics

BOIRON SA

EPA:BOI (4/7/2026, 7:00:00 PM)

27.8

-0.2 (-0.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)04-02
Earnings (Next)N/A
Inst Owners5.47%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap487.89M
Revenue(TTM)504.86M
Net Income(TTM)19.37M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.62%
Yearly Dividend1.35
Dividend Growth(5Y)-1.41%
DP107.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 24.82
Fwd PE 12.02
P/S 0.97
P/FCF 13.08
P/OCF 9.22
P/B 1.32
P/tB 1.95
EV/EBITDA 6.03
EPS(TTM)1.12
EY4.03%
EPS(NY)2.31
Fwd EY8.32%
FCF(TTM)2.12
FCFY7.64%
OCF(TTM)3.02
OCFY10.85%
SpS28.77
BVpS21.03
TBVpS14.24
PEG (NY)4.49
PEG (5Y)N/A
Graham Number23.02
Profitability
Industry RankSector Rank
ROA 3.45%
ROE 5.25%
ROCE 5.9%
ROIC 4.43%
ROICexc 5.25%
ROICexgc 7.65%
OM 5.26%
PM (TTM) 3.84%
GM 73.71%
FCFM 7.39%
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
ROICexc(3y)8.01%
ROICexc(5y)8.34%
ROICexgc(3y)11.86%
ROICexgc(5y)12.41%
ROCE(3y)7.49%
ROCE(5y)7.29%
ROICexgc growth 3Y-33.41%
ROICexgc growth 5Y-24.37%
ROICexc growth 3Y-32.4%
ROICexc growth 5Y-24.82%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.49
Debt/EBITDA 0.2
Cap/Depr 35.13%
Cap/Sales 3.1%
Interest Coverage 30.02
Cash Conversion 74.49%
Profit Quality 192.52%
Current Ratio 2.39
Quick Ratio 1.46
Altman-Z 3.64
F-Score7
WACC7.97%
ROIC/WACC0.56
Cap/Depr(3y)71.98%
Cap/Depr(5y)71.7%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.78%
Profit Quality(3y)124.88%
Profit Quality(5y)120.26%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.09%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
EBIT growth 1Y-11.18%
EBIT growth 3Y-30.48%
EBIT growth 5Y-25.59%
EBIT Next Year86.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y113.74%
FCF growth 3Y22.31%
FCF growth 5Y12.1%
OCF growth 1Y57.85%
OCF growth 3Y5.87%
OCF growth 5Y-4.91%

BOIRON SA / BOI.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BOIRON SA?

ChartMill assigns a fundamental rating of 5 / 10 to BOI.PA.


What is the valuation status of BOIRON SA (BOI.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to BOIRON SA (BOI.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for BOIRON SA?

BOIRON SA (BOI.PA) has a profitability rating of 4 / 10.


How financially healthy is BOIRON SA?

The financial health rating of BOIRON SA (BOI.PA) is 7 / 10.


Can you provide the dividend sustainability for BOI stock?

The dividend rating of BOIRON SA (BOI.PA) is 5 / 10 and the dividend payout ratio is 107.57%.